Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biohaven Pharmaceutical Holding Co Ltd.

20.55
-3.1300-13.22%
Post-market: 20.54-0.0100-0.05%18:51 EDT
Volume:2.68M
Turnover:56.32M
Market Cap:2.10B
PE:-2.22
High:22.24
Open:21.95
Low:20.41
Close:23.68
Loading ...
Feb 29, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Dec 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2023

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 19, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 06, 2023

Major Issues Report

Form 8-K - Current report
Oct 03, 2023

Major Issues Report

Form 8-K - Current report
Sep 27, 2023

Major Issues Report

Form 8-K - Current report
Jul 31, 2023

Major Issues Report

Form 8-K - Current report
Jul 31, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 29, 2023

Major Issues Report

Form 8-K - Current report
May 31, 2023

Major Issues Report

Form 8-K - Current report
May 12, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 12, 2023

Major Issues Report

Form 8-K - Current report
Oct 04, 2022

Delisting

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Oct 03, 2022

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments